In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1815 News Items found
A researcher working in an MSK lab
MSK Research Highlights, January 17, 2025

MSK research provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis of brain diseases by revealing how different parts of the brain are metabolizing nutrients; describes a new method to aid the study of rare but influential cell populations; and identifies a potential treatment for malignant peripheral nerve sheath tumors.
MSK patient Aaron von Freter
Newly Approved Pill for Chronic Myeloid Leukemia Offers Greater Hope for Cure 

MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.
Ask the Expert
Black male prostate cancer patient smiling.
Why Black Men Should Consider Earlier Screening for Prostate Cancer

Learn why Black men should be especially mindful of prostate cancer risk.
Article
MSK surgeon-scientist Vinod Balachandran.
Cancer Researchers Shed Light on How Tertiary Lymphoid Structures Form

Read about new findings on how tertiary lymphoid structures form to fight foreign threats such as cancer.
Adrienne Boire
Beyond the Bench: Neuro-Oncologist Adrienne Boire

Neuro-oncologist Dr. Adrienne Boire discusses her path to becoming a cancer researcher, and on the parallel between science and another passion — knitting.
Dr. Debyani Chakravarty
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.
Luc Morris
New AI Tool Uses Routine Blood Tests to Predict Immunotherapy Response for Many Cancers

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.
Close-up of hand holding glass of red wine.
Does Drinking Alcohol Cause Cancer? Learn About the Risks

Learn more about the link between drinking alcohol and the risk of developing cancer.
Seungjae Lee and Eric Lai
The Secret Life of ALAS1: How a Basic Science Discovery Could Pave the Way for Better siRNA Therapies

New findings by researchers at MSK and their collaborators at the Icahn School of Medicine point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer.
A researcher working in an MSK lab
MSK Research Highlights, December 18, 2024

New MSK research uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT® could be used for HLA genotype screening to predict response to cellular therapies; identifies a possible strategy to overcome immune evasion in ovarian cancer; and finds strong support for telemedicine visits among cancer patients.